Tectonic Therapeutic

1 follower


Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).

Industries

Headquarters

Stage

Employees

Links

Org chart

Alise Reicin
President & CEO & Director

Alise Reicin

Collapse
Christian Cortis
Chief Operating Officer
Anthony Muslin
Chief Development Officer
Marc Schwabish
Chief Business Officer
Marcella Ruddy
Chief Medical Officer
Barry Rubenstein
SVP, People & Culture
Washington Alves
VP, Biologics Manufacturing
Peter McNamara
Head of Research
Anthony (Tony) Muslin
Chief Development Officer
Jaime Darce
Senior Director, Pharmacology
John Diener
Senior Vice President
Joseph Toth
Director
Kathryn Bracken
Associate Vice President, Program Management
Rohit Anand
Executive Director Of Finance & Controller
Yao Fan
Director, Protein Design and Optimization
Arthur MARIVIN, PhD
Principal Scientist - Head Of Cell Biology
Emilie Ogisu
Associate Scientist
Hitesh Soni, Ph.D., MBA
Director, In Vivo Pharmacology/immunology
Jason Booe
Sr. Scientist
Joana Khatib
Senior Research Associate
John Fernandez
Senior Research Associate
Katelyn Pyper
Senior Research Associate
Lindsay Clark
Senior Scientist
Luke Turechek
Principal Scientist
Mounika Rao
Senior Research Associate
Othman Benchama
Scientist - Cell Pharmacology
Peter Marek
Principal Scientist
Sarah Nordeen
Senior Scientist, Antibody Discovery And Engineering
Sarulatha Thulasi Raman
Senior Research Associate
Sriram Kollipara
Principal Scientist/ Associate Director
Thomas McElrath
Research and Product Development Consultant
Vasudha Sharma
Senior Research Associate
Victoria Jenny
Scientist II
Zachary MacBain
Sr. Research Associate
Xiaofei Li, PhD
Scientist II
Rebecca Smith
Sr. Laboratory Associate
Ashley Smith
Senior Manager, Executive Administration